An alternative strategy is targeting WDR5, crucial for GSC self-renewal and tumor initiation, by disrupting the epigenetic maintenance of GSCs and circumventing the challenges of directly targeting transcription factors like SOX2 [37,38]. The gene discussed is WDR5; the disease is neoplasm.